Subject Recruitment & Trial Finding

TrialCentralNet, by TCN e-Systems

In late July, trial enrollment specialist TCN e-Systems introduced mobility via smartphone to its TrialCentralNet e-clinical solution--an app that addresses the needs of clinical teams. TrialCentralNet gives users access to study-goal information, enrollment numbers, key dates, country information, and media metrics through the iPhone and Blackberry. Version 5.2 broadens the solution's language offerings. Those supported are Chinese, Dutch, English, French, German, Hindi, Italian, Japanese, Polish, Portuguese, Russian and Spanish. Release

CancerTrials App, by GlaxoSmithKline and Medtrust

CancerTrials App helps doctors find trials for patients. It's developed for the iPhone and iPad and connects to MedTrust Online's oncology databases. The free application provides a search menu based on 12 common cancers. Users can refine searches based on such criteria as subject gender and age, and trial status. Once users locate relevant trials, they can map results relative to the iPhone location. Release

CT, by TrialX

Healthcare IT company TrialX launched an application in April 2009 that allows Twitter users to find clinical trials. Users tweet TrialX using the keyword "CT" for clinical trial, and provide a few health profile details ("I'm a 55 year-old male with prostate cancer looking for trials in Columbus, OH"). They get a reply tweet to the TrialX page containing matching trials. Release | TrialX Twitter page

Clinical Trial 2.0, from Healogica

For $0.99, you can search tens of thousands of clinical trials by disease or condition. Healogica-Clinical Trial 2.0 functions as a monster.com for clinical trials by pairing subjects and trials via a matching algorithm. App |
Announcement

Subject Recruitment & Trial Finding
Read more on

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.